Ascom Holding AG (ACMLF)
USD 3.64
(-44.0%)
USD 3.64
(-44.0%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 297.3 Million CHF | -0.03% |
| 2022 | 297.4 Million CHF | 2.02% |
| 2021 | 291.5 Million CHF | 3.74% |
| 2020 | 281 Million CHF | -0.67% |
| 2019 | 282.9 Million CHF | -11.18% |
| 2018 | 318.5 Million CHF | 2.84% |
| 2017 | 309.7 Million CHF | -12.59% |
| 2016 | 354.3 Million CHF | -13.75% |
| 2015 | 410.8 Million CHF | -8.47% |
| 2014 | 448.8 Million CHF | -2.37% |
| 2013 | 459.7 Million CHF | 2.2% |
| 2012 | 449.8 Million CHF | 2.81% |
| 2011 | 437.5 Million CHF | -23.41% |
| 2010 | 571.2 Million CHF | 6.33% |
| 2009 | 537.2 Million CHF | 5.5% |
| 2008 | 509.2 Million CHF | 3.81% |
| 2007 | 490.5 Million CHF | 3.28% |
| 2006 | 474.9 Million CHF | -31.03% |
| 2005 | 688.6 Million CHF | -43.55% |
| 2004 | 1.21 Billion CHF | -19.47% |
| 2003 | 1.51 Billion CHF | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q2 | 71.05 Million CHF | 0.0% |
| 2024 Q1 | 71.05 Million CHF | -51.7% |
| 2023 Q1 | 75.1 Million CHF | -51.11% |
| 2023 Q2 | 150.2 Million CHF | 100.0% |
| 2023 Q4 | 147.1 Million CHF | 100.0% |
| 2023 FY | 297.3 Million CHF | -0.03% |
| 2023 Q3 | 73.55 Million CHF | -51.03% |
| 2022 Q4 | 153.6 Million CHF | 100.0% |
| 2022 Q1 | 71.9 Million CHF | -52.51% |
| 2022 Q2 | 143.8 Million CHF | 100.0% |
| 2022 Q3 | 76.8 Million CHF | -46.59% |
| 2022 FY | 297.4 Million CHF | 2.02% |
| 2021 Q3 | 75.7 Million CHF | -45.97% |
| 2021 Q1 | 70.05 Million CHF | -52.54% |
| 2021 Q2 | 140.1 Million CHF | 100.0% |
| 2021 Q4 | 151.4 Million CHF | 100.0% |
| 2021 FY | 291.5 Million CHF | 3.74% |
| 2020 FY | 281 Million CHF | -0.67% |
| 2020 Q2 | 133.4 Million CHF | 100.0% |
| 2020 Q1 | 66.7 Million CHF | -54.28% |
| 2020 Q4 | 147.6 Million CHF | 100.0% |
| 2020 Q3 | 73.8 Million CHF | -44.68% |
| 2019 Q4 | 145.9 Million CHF | 100.0% |
| 2019 Q3 | 72.95 Million CHF | 6.5% |
| 2019 Q2 | 68.5 Million CHF | 0.0% |
| 2019 Q1 | 68.5 Million CHF | -20.16% |
| 2019 FY | 282.9 Million CHF | -11.18% |
| 2018 Q1 | 73.45 Million CHF | -11.77% |
| 2018 Q2 | 73.45 Million CHF | 0.0% |
| 2018 FY | 318.5 Million CHF | 2.84% |
| 2018 Q3 | 85.8 Million CHF | 16.81% |
| 2018 Q4 | 85.8 Million CHF | 0.0% |
| 2017 Q3 | 83.25 Million CHF | 16.27% |
| 2017 FY | 309.7 Million CHF | -12.59% |
| 2017 Q2 | 71.6 Million CHF | 0.0% |
| 2017 Q1 | 71.6 Million CHF | -17.23% |
| 2017 Q4 | 83.25 Million CHF | 0.0% |
| 2016 Q1 | 90.65 Million CHF | -13.34% |
| 2016 Q4 | 86.5 Million CHF | 0.0% |
| 2016 FY | 354.3 Million CHF | -13.75% |
| 2016 Q2 | 90.65 Million CHF | 0.0% |
| 2016 Q3 | 86.5 Million CHF | -4.58% |
| 2015 Q2 | 100.8 Million CHF | 0.0% |
| 2015 Q3 | 104.6 Million CHF | 3.77% |
| 2015 FY | 410.8 Million CHF | -8.47% |
| 2015 Q1 | 100.8 Million CHF | -14.21% |
| 2015 Q4 | 104.6 Million CHF | 0.0% |
| 2014 Q1 | 101.35 Million CHF | -13.6% |
| 2014 FY | 448.8 Million CHF | -2.37% |
| 2014 Q4 | 117.5 Million CHF | 0.0% |
| 2014 Q3 | 117.5 Million CHF | 15.93% |
| 2014 Q2 | 101.35 Million CHF | 0.0% |
| 2013 Q4 | 117.3 Million CHF | 0.0% |
| 2013 Q1 | 112.55 Million CHF | 0.0% |
| 2013 Q2 | 112.55 Million CHF | 0.0% |
| 2013 FY | 459.7 Million CHF | 2.2% |
| 2013 Q3 | 117.3 Million CHF | 4.22% |
| 2012 FY | 449.8 Million CHF | 2.81% |
| 2011 FY | 437.5 Million CHF | -23.41% |
| 2010 FY | 571.2 Million CHF | 6.33% |
| 2009 FY | 537.2 Million CHF | 5.5% |
| 2008 FY | 509.2 Million CHF | 3.81% |
| 2007 FY | 490.5 Million CHF | 3.28% |
| 2006 FY | 474.9 Million CHF | -31.03% |
| 2005 FY | 688.6 Million CHF | -43.55% |
| 2004 FY | 1.21 Billion CHF | -19.47% |
| 2003 FY | 1.51 Billion CHF | 0.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| Achiko AG | 62.5 Thousand USD | -475526.73% |
| Accelera Innovations, Inc | - USD | -Infinity% |
| Aspyra Inc. | 8.52 Million USD | -3386.964% |
| Cannabis Sativa, Inc. | 1.17 Million USD | -25227.347% |
| CompuMed, Inc. | 5.83 Million USD | -4992.402% |
| CompuGroup Medical SE & Co. KGaA | 1.31 Billion USD | 77.32% |
| Cogstate Limited | 43.42 Million USD | -584.585% |
| CareView Communications, Inc. | 9.68 Million USD | -2969.816% |
| Craneware plc | 189.26 Million USD | -57.079% |
| Caduceus Software Systems Corp. | 6.58 Million USD | -4412.535% |
| Certive Solutions Inc. | 1.27 Million USD | -23302.557% |
| Drug Free Solution, Inc. | 805.00 USD | -36931577.019% |
| DATATRAK International, Inc. | 6.18 Million USD | -4707.362% |
| Strainsforpains, Inc. | 84.11 Thousand USD | -353340.487% |
| Healixa Inc. | 598.88 Thousand USD | -49542.252% |
| Easy Technologies Inc. | - USD | -Infinity% |
| eWellness Healthcare Corporation | - USD | -Infinity% |
| Founders Bay Holdings | 16.45 Million USD | -1706.33% |
| Health Discovery Corporation | - USD | -Infinity% |
| Healthcare Integrated Technologies, Inc. | 322 Thousand USD | -92229.193% |
| H-Source Holdings Ltd. | - USD | -Infinity% |
| InterCare DX, Inc. | - USD | -Infinity% |
| IQ-AI Limited | 775.75 Thousand USD | -38224.054% |
| Cannabiz Mobile, Inc. | - USD | -Infinity% |
| Mednow Inc. | 12.99 Million USD | -2187.545% |
| Galileo Life Sciences, Inc. | - USD | -Infinity% |
| MediXall Group, Inc. | 59.26 Thousand USD | -501519.761% |
| Mitesco, Inc. | - USD | -Infinity% |
| MobileSmith, Inc. | 1.57 Million USD | -18801.585% |
| NantHealth, Inc. | 67 Million USD | -343.718% |
| Net Medical Xpress Solutions, Inc. | 597 Thousand USD | -49698.995% |
| OneLife Technologies Corp. | - USD | -Infinity% |
| ORHub, Inc. | 324.86 Thousand USD | -91413.81% |
| Patient Access Solutions, Inc. | 212.73 Thousand USD | -139650.677% |
| Pharma-Bio Serv, Inc. | 16.97 Million USD | -1651.208% |
| PPJ Healthcare Enterprises, Inc. | 711.03 Thousand USD | -41712.053% |
| Medical Cannabis Payment Solutions, Inc. | - USD | -Infinity% |
| Renalytix Plc | 2.28 Million USD | -12888.204% |
| Revium Recovery Inc. | - USD | -Infinity% |
| RYAH Group, Inc. | - USD | -Infinity% |
| Carepay Inc. | 1.46 Million USD | -20202.523% |
| Vaso Corporation | 81.02 Million USD | -266.928% |
| Vynleads, Inc. | - USD | -Infinity% |